Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Medioni

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Radiology|June 17, 2010
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CTLaure S Fournier, Stephane Oudard, Rokhaya Thiam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT studyFlorent Hugonnet, Laure Fournier, Jacques Medioni, et al.
The Journal of Urology|April 18, 2007
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) studyStéphane Oudard, Eugeniu Banu, Annick Vieillefond, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancerFeby Mardjuadi, Jacques Medioni, Joseph Kerger, et al.
Journal of Translational Medicine|July 27, 2010
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activityChrystelle Brignone, Maya Gutierrez, Fawzia Mefti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2012
Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: analysis of response and progression-free survival in the RECORD-1 studyStéphane Oudard, Rokhaya Thiam, Laure S Fournier, et al.
Drugs in R&D|June 18, 2011
Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumorsJacques Medioni, Cyrille Huchon, Marie-Aude Le Frere-Belda, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
Cancer|May 17, 2002
Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter studyFrederique Sauvat, Sabine Sarnacki, Herve Brisse, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2020
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patientsPierre Rosenbaum, Cécile Artaud, Sylvie Bay, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Radiology|June 17, 2010
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CTLaure S Fournier, Stephane Oudard, Rokhaya Thiam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT studyFlorent Hugonnet, Laure Fournier, Jacques Medioni, et al.
The Journal of Urology|April 18, 2007
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) studyStéphane Oudard, Eugeniu Banu, Annick Vieillefond, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancerFeby Mardjuadi, Jacques Medioni, Joseph Kerger, et al.
Journal of Translational Medicine|July 27, 2010
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activityChrystelle Brignone, Maya Gutierrez, Fawzia Mefti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2012
Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: analysis of response and progression-free survival in the RECORD-1 studyStéphane Oudard, Rokhaya Thiam, Laure S Fournier, et al.
Drugs in R&D|June 18, 2011
Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumorsJacques Medioni, Cyrille Huchon, Marie-Aude Le Frere-Belda, et al.
Melanoma Research|October 28, 2009
Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patientsSarah Zohar, Jacques Medioni, Céleste Lebbé, et al.
Cancer|May 17, 2002
Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter studyFrederique Sauvat, Sabine Sarnacki, Herve Brisse, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2020
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patientsPierre Rosenbaum, Cécile Artaud, Sylvie Bay, et al.
Pageof 6